The effect of inhaled corticosteroids on hair cortisol Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations Year: 2018
Repeated inhalation of the new topical steroid ciclesonide does not lead to suppression of endogenous cortisol release in healthy subjects Source: Eur Respir J 2001; 18: Suppl. 33, 95s Year: 2001
Inhaled anticholinergic drugs and risk of acute urinary retention Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases Year: 2008
Overnight urinary isoprostane levels during CPAP withdrawal as a marker of oxidative stress Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
The effect of hypnotics on next day’s diurnal symptoms in hypercapnic patients receiving long-term nocturnal noninvasive ventilation. Source: International Congress 2019 – Beyond continuous positive airway pressure treatment Year: 2019
Differences in the glucocorticoid to progesterone receptor selectivity of inhaled glucocorticoids Source: Eur Respir J 2006; 27: 511-516 Year: 2006
Obesity and severity of nocturnal desaturations have synergestic effects on the increased urinary excretion of leukotriene E4 in sleep apnea syndrome Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP Source: Eur Respir J 2007; 30: 496-500 Year: 2007
Low dose theophylline restores steroid insensitivity in PBMCs of steroid insensitive asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 347s Year: 2004
Mepolizumab decreases urinary excretion of LTE4 in severe asthma Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020
Tpi 1020, a novel inhaled anti-inflammatory drug, has a different pharmacokinetic profile and lower effect on urinary free cortisol as compared to budesonide Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009
One year vitamin D and parathyroid hormone influence in patients with OSAS and CPAP treatment Source: International Congress 2018 – Treatments that can serve as an alternative to positive airway pressure (PAP) Year: 2018
Medroxyprogesterone in postmenopausal females with partial upper airway obstruction during sleep Source: Eur Respir J 2001; 18: 989-995 Year: 2001
Clenbuterol antagonize the effect of chronic administration of steroid respiratory muscle in mice Source: Eur Respir J 2002; 20: Suppl. 38, 496s Year: 2002
Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
3 month continuous positive airway pressure (CPAP) therapy decreases serum lipids, but not homocysteine and leptin concentration in patients with OSAS Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009
Effect of 3-month CPAP treatment on blood pressure and serum aldosterone concentration in patients with resistant hypertension Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013
Obesity-hypoventilation-syndrome: the role of nocturnal CPAP therapy Source: Eur Respir J 2004; 24: Suppl. 48, 568s Year: 2004
Biomarker-high patients and steroid responsiveness Source: International Congress 2018 – PG17 Asthma phenotyping Year: 2018
The influence of glucocorticoid therapy on the level of sex hormones in menopausal women with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 51s Year: 2002